Should Lung Cancer Screening Be Suspended During a Pandemic?
Ann Thorac Surg
.
2022 Jan;113(1):9-12.
doi: 10.1016/j.athoracsur.2021.08.032.
Epub 2021 Sep 22.
Authors
Barry C Gibney
1
,
Robert M Sade
2
,
Frank C Detterbeck
3
,
Douglas E Wood
4
Affiliations
1
Department of Surgery, Medical University of South Carolina, Charleston, South Carolina. Electronic address: gibney@musc.edu.
2
Department of Surgery, Medical University of South Carolina, Charleston, South Carolina.
3
Department of Surgery, Yale University, New Haven, Connecticut.
4
Department of Surgery, University of Washington, Seattle, Washington.
PMID:
34560045
PMCID:
PMC8658699
DOI:
10.1016/j.athoracsur.2021.08.032
No abstract available
Publication types
Editorial
MeSH terms
Aged
COVID-19 / epidemiology*
Early Detection of Cancer*
Humans
Lung Neoplasms / diagnosis*
Lung Neoplasms / therapy
Middle Aged
SARS-CoV-2*
Time-to-Treatment
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States